Screen-Based Distraction Tool for Preoperative Preparation
NCT ID: NCT03014466
Last Updated: 2018-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2017-01-31
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interventions for Sleep Problems in Early Childhood
NCT01489215
Mindfulness for Pediatric Chest Pain
NCT05939492
Digital Sleep Optimization for Brain Health Outcomes in Older Surgical Patients
NCT06375265
Cognitive Behavioral Treatment for Improving Sleep in Overweight and Obese Youth
NCT02232217
Treatment for Insomnia During Pregnancy
NCT01846585
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Upon arrival for preoperative preparations, the research assistant will go over the consent and assent forms with the parent and child and answer any questions they may have about the study. While child is being prepped to be transported to the preoperative holding area, a research staff member will determine whether the participant will receive the standard care (i.e. entertainment via tablet) or the (i.e. BERT, Bedside EnteRtainment System; Video Projection) via random assignment. Once determined, the research staff will set up the system for the patient and will be asked to fill out questionnaires, on REDCap or by paper, about how they are feeling at that time before their surgery. Parents will also be asked to fill out questionnaires about their feelings of their child's preoperative emotions. The child will continue to view their preoperative entertainment through to induction. A video camera mounted to the BERT screen or tablet will be used for retrospective coding by blinded research assistants. When possible, a blinded research assistant will also live-code the observer-rated surveys. We aim for this to occur for around 20-30% of participants. care) The research assistants will complete the mYPAS (modified Yale Preoperative Anxiety Scale) and ICC (Induction Compliance Checklist) when coding in vivo. Vitals (i.e. blood pressure, heart rate, oxygen saturation, end tidal CO2, and temperature) will also be recorded as they undergo preoperative preparations. The parent will be asked to remain with their child from the preoperative holding area until the child has undergone induction. Once child enters induction phase in the OR, the patient will undergo surgery as scheduled.
Post-operation, the research assistant will further examine the child's behaviors as they wake from anesthesia. They will also give the the parent, child, and child's anesthesiologist a survey about their experiences with the screen-based device. 1 week after the surgery, the research assistant will follow up with the parent/guardian with questions about their and their child's preoperative and perioperative via phone. The call will also be audio recorded. After the one-week follow-up survey, the study will be concluded for the participant.
b) Explain how the above research procedures are the least risky that can be performed consistent with sound research design.
All survey questions are meant to answer questions pertaining to the study aims. Set up of the Video Projection unit will be performed by trained members of the research team and will be of minimal risk to patients.
The risks associated with this study include the possibility of participation being discovered by others outside of the study team. This is highly unlikely given the precautions that will be described later in this application.
c) State if deception will be used. If so, provide the rationale and describe debriefing procedures. Since you will not be fully informing the participant in your consent process and form, complete an alteration of consent (in section 13). Submit a debriefing script (in section 16).
Deception will not be used.
d) State if audio or video recording will occur. Describe what will become of the recording after use, e.g., shown at scientific meetings, erased. Describe the final disposition of the recordings.
Participants will be video taped to capture the patient's full experience with the Video Projection unit and its effect during preoperative and perioperative procedure. The video camera will be mounted on the tablet or BERT system. Videos will be coded by the research team, and will not contain PHI. Audio will be recorded from the follow-up phone calls so that the parents' responses will be fully captured in our measures. These videos and audio files will be stored on a secured, password protected, and encrypted computer, which only authorized members of the study will have access to. The videos and audio files will be destroyed 6 years after the publication of the study. These videos and audio files may be presented at scientific meetings and this will be included in the consent.
e) Describe alternative procedures or courses of treatment, if any, that might be advantageous to the participant. Describe potential risks and benefits associated with these. Any standard treatment that is being withheld must be disclosed in the consent process and form. (i.e. standard-of-care drug, different interventional procedure, no procedure or treatment, palliative care, other research studies).
This is a randomized trial to validate the effectiveness of using a Video Projection unit, therefore there will be subjects that undergo standard treatment as a result of the randomization. The randomization will be performed by the research assistant following consent. Parents must be with their child from the pre-operative area until induction. They will have the option to opt-out of the study if the parent or child does not want the parent present or there is a strong patient or parent preference for pharmacological anxiolytic or a specific anxiety-reduction technique.
f) Will it be possible to continue the more (most) appropriate therapy for the participant(s) after the conclusion of the study?
N/A. The interventional technologies will only be implemented to allay preoperative anxiety, therefore will not be continued after the surgery.
g) Study Endpoint. What are the guidelines or end points by which you can evaluate the different treatments (i.e. study drug, device, procedure) during the study? If one proves to be clearly more effective than another (or others) during the course of a study, will the study be terminated before the projected total participant population has been enrolled? When will the study end if no important differences are detected?
The endpoint of the study will be determined by the completion of the target number of participants. The target number of participants for the study is 30 participants in each randomized group (i.e. standard care tablet and Video Projection unit group) for a total of 60 patients who complete the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tablet
Preoperative patients will utilize a video tablet for addressing pre anesthesia anxiety
Use of Video Tablet
7 inch video tablet that is used for displaying videos of the patient's choosing prior to induction of anesthesia
Video Projector
Preoperative patients will utilize a video projection unit for addressing pre anesthesia anxiety
Use of Video Projector
Bed mounted video projector that is used to play videos of the patient's choosing prior to induction of anesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Use of Video Projector
Bed mounted video projector that is used to play videos of the patient's choosing prior to induction of anesthesia
Use of Video Tablet
7 inch video tablet that is used for displaying videos of the patient's choosing prior to induction of anesthesia
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. be between ages of 4-10 years of age
2. have comprehension of instructions in the English language
3. have parental consent
4. Pediatric patient must be undergoing non-emergent outpatient surgery at Lucile Packard Children's Hospital
5. Children who are normally healthy (ASA I) or have a mild systemic disease (ASA II) -
Exclusion Criteria
2. Children with ASA III, ASA IV (severe systemic disease that is a constant threat to life) or ASA V (unstable patients not expected to survive \>24hours or without the operation)
3. Children currently taking psychotropic mediations will be excluded from this study due to the affect emotion modulation
4. Strong parental or patient preference for pharmacological anxiolytic
5. Strong parental or patient preference for specific anxiety-reducing technique
6. Children born before 32 week gestation
7. Any indication that the patient may be admitted post-operatively
8. Child has had previous surgery or has undergone general anesthesia
9. Parent does not want to be present during transport to the OR or during induction -
4 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samuel Rodriguez
Clinical Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samuel T Rodriguez, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford School of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-37577
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.